Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The document discusses various challenging skin conditions and their treatments.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Stem-cell therapy shows promise for skin conditions but needs more research.

Finasteride improves hair growth.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Hair chemicals don't cause SLE but may increase skin issues in those with SLE.

SLE and DM can coexist but are rare and need careful evaluation.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.